期刊文献+

生长激素在卵巢储备功能低下患者IVF治疗中的应用 被引量:8

An application research of growth hormone on Ovarian reserve dysfunction patients in IVF cycle
原文传递
导出
摘要 目的探讨生长激素在体外受精-胚胎移植中对卵巢储备功能低下患者控制性超排卵的作用。方法将符合卵巢储备功能低下患者的不孕症患者,随机分为生长激素组(50例)和对照组(50例),均采用拮抗剂方案,其中生长激素组从周期第2-3d每天注射4.5IU生长激素直至HCG日,比较两组超排卵的治疗过程及结局。结果两组患者在年龄、基础FSH及E_2水平、窦卵泡数目方面比较均无显著差异。研究组的Gn使用天数以及Gn用量低于对照组,差异有显著性(P<0.05);研究组的获卵数目以及HCG日E_2水平高于对照组,差异有显著性(P<0.05)。研究组的受精率、卵裂率、优胚率略高于对照组,但差异无显著性(P>0.05);研究组的HCG日子宫内膜厚度、P水平略高于对照组,差异无显著性(P>0.05)。结论在卵巢储备功能低下患者,在促排卵过程中加用生长激素可以降低Gn的使用量,增加获卵数及HCG日雌激素的水平。 Objective: To investigale the application of GH to the patients with Ovarian reserve dysfunction. Methods: 100 infertility patients with Ovarian reserve dysfunction were divided into GH group and control group in random. Each cycle was used the antagonist protocol, the patients in GH geoup were administrated GH 4.5IU everyday from menstruation 2-3 days. The processe of controlled ovarian hyperstimulation and outcome were compared. Results: There were no significant differences in age, basal FSH and E2 levels, and the number of antral follicles between the two groups. The doses and duration of gonadotropin in the study group was lower than that in the control group, the difference was significant (P〈0.05) ; the number of oocytes retrieved and the mesh 17 beta-estradiol levels on the day of HCG were higher in the study group than in the control group, the difference was significant (P〈0.05) . Research group in the fertilization rate, cleavage rate, good quality embryo rate slightly higher than that of control group, but the difference was not significant (P〉0.05) ; The uterine endometrial thickness and P levels on the day of HCG in study group wre slightly higher than that in control group, the difference was not significant (P〉0.05) . Conclusion: In patients with low ovarian reserve function, combined with growth hormone during the controlled ovarian hyperstimulation will reduce the doses of gonadotropin, increase the number of oocytes retrieved and the mesn 17 beta-estradiol levels on the day of HCG.
作者 赵振钏 亓蓉 梁莹 周莉 吴晓茜 高星 陶建芳 ZHAO Zhen- chuan QI Rong LIANG Ying ZHOU Li WU Xiao-qian TAO Jian-fang(The Retroduction Center of the Fourth Hospital of Shijiazhuang , Shijiazhuang Hebei 050000, Chin)
出处 《中国优生与遗传杂志》 2017年第1期125-126,97,共3页 Chinese Journal of Birth Health & Heredity
基金 石家庄市科技局科技支撑计划 编号:141462893
关键词 生长激素 卵巢储备功能低下 体外受精-胚胎移植 Growth hormone Low ovarian reserve function In vitro fertilization and embryo transfer
  • 相关文献

参考文献3

二级参考文献56

  • 1马瑞芬,陆海娟,施孝文.中药合穴位针刺治疗排卵障碍性不孕疗效观察[J].浙江中西医结合杂志,2006,16(1):62-62. 被引量:19
  • 2Polyzos NP, Devroey P. A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel? Fertil Steril, 2011, 96(5): 1058-61.e7.
  • 3Gareia JE, Jones GS, Acosta AA, et al. Human menopausal gonadotropin/human chorionic gonadotropin follicular matu- ration for oocyte aspiration: phase II, 1981. Fertil Steril, 1983, 39(2):167-73.
  • 4Campbell S, Goessens L, Goswamy R, et al. Real-time ullrasonog- mphy for determination of ovarian morphology and volume. A possible early screening test for ovarian cancer?. Lancet, 1982, 20 (1):425-6.
  • 5Gougeon A. Ovarian follicular growth in humans: ovarian ageing and population of growing follicles. Maturitas, 1998, 30(2): 137-42.
  • 6Chang MY, Chiang CH, Hsieh TF, etal. Use ofthe antral follicle count to predict the outcome of assisted reproductive technologies. Fertil Steril, 1998, 69(3):505-10.
  • 7Fetranretti AP, La Marea A, Fauster BC, et al. ESHRE working group on poor ovarian respone definition. ESHRE consensus on the definition of'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod, 2011, 26(7): 1616-24.
  • 8EI-Toukhy T, Khalaf Y, Hart R, et al. Yotmg age does not protect against the adverse effects of reduced ovarian reserve an eight year study. Hum Reprod, 2002, 17(6): 1519-24.
  • 9Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting meagures of ovarian reserve: a committee opinion. Fertil Steril, 2012, 98(6): 1407-15.
  • 10Tsepelidis S, Devreker F, Demeestere I, et al. Stable serum levels of anti-Miillerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women. Hum Reprod, 2007, 22(7): 1837-40.

共引文献252

同被引文献63

引证文献8

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部